Results 101 to 110 of about 1,367,790 (258)

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Creative drama in English class: Boosting student self-esteem through innovation

open access: yesInovasi Kurikulum
In Indonesia, the integration of creative drama into the formal curriculum has not been widely or systematically implemented, leaving substantial room for the development of students' emotional aspects, especially self-esteem, as an area of potential ...
Syahal Waludin, Sri Setyarini
doaj   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Media Release - Generate Design - Creative Partnerships Australia.pdf

open access: yes, 2015
Media release from Creative Partnerships Australia announcing the federally funded program Generate Design, a business strategy and mentoring program with a $100,00 investment in the growth and development of the Australian graphic design industry.
Creative Partnerships Australia, Creative Industries Innovation Centre
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Creative Business Consultations - Newcastle 2011.pdf

open access: yes, 2015
Creative Industries Innovation Centre - Creative Business Consultations flyer, Newcastle ...
Creative Industries Innovation Centre
core  

Getting creative in healthcare: the contribution of creative activities to Australian healthcare [PDF]

open access: yes, 2008
Executive summary Creative skills are widely distributed across economies, but their contributions to economic performance and social outcomes and their role in enabling nations and institutions to respond to competitive and other pressures are not ...
Stuart Cunningham   +5 more
core   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Creative Industries Innovation Centre Closure Q&A.pdf

open access: yes, 2015
Information about the of the Creative Industries Innovation Centre in Q&A form, with information about creative business support services through the Entrepreneurs' Infrastructure Programme, final Biztro sessions, and a link to the Creative Industries ...
Creative Industries Innovation Centre
core  

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy